An observational study in Feeding Disorders, sponsored by Lori Erickson. Enrolling by invitation at 1 site in United States. Open to participants aged 1 Month to 6 Years. Per ClinicalTrials.gov, last updated 2026-09-02.
Sponsored by Lori Erickson · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 259 studies in Feeding and Eating Disorders with a site in United States — 35 open to participants now, 49 under way, none of them phase 3. Feeding and Eating Disorders · United States.
Among the 259 studies in Feeding and Eating Disorders with a site in United States, this one is the 11th largest by planned enrollment of the 43 observational ones that give a count, is one of 17 that started in 2023, is one of 43 observational ones, reaches primary completion later than 30 of the 48 other live ones, and was the 212th registered.
645 studies on the registry are indexed under Feeding and Eating Disorders; 151 are open to participants now.
Browse Feeding and Eating Disorders studies →35 of the 259 studies in Feeding and Eating Disorders with a site in United States are open now. Recruiting first, the newest first:
Medical University of South Carolina · Sites in United States
Ages up to 6 mo
Duke University · Sites in United States
Ages 15–25
Duke University · Sites in United States
Ages 18–25
Washington University School of Medicine · Sites in United States
Ages 18+
Trustees of Dartmouth College · Sites in United States
Ages 18–70
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 99 Feeding and Eating Disorders studies recruiting now, 31 (31%) set no upper age limit and 66 (67%) stop at 75 or younger; 45 take children under 18; 20 take healthy volunteers.
This study: 1 Month to 6 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
259 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 20 · Phase 2 19 · Phase 3 7 · Phase 4 6
First in 1995; this study’s year is marked. 17 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 245 is above the median of 102 across 177 observational studies indexed under Feeding and Eating Disorders.
Median enrollment 66 across the 215 interventional studies, 90 across the 43 observational. Of the 201 that completed or were terminated, 49 (24%) have results posted.
This tab as a report to print or save as PDF → With an account.
8 of 259 have an industry lead sponsor. The 10 most frequent:
Lori Erickson is the lead sponsor of 2 studies on the registry; 2 are open to participants now.
Lori Erickson has 1 study filed under Feeding and Eating Disorders — fewer than ten, so there is no comparison to draw.
28 of the studies in Feeding and Eating Disorders with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06858774Icahn School of Medicine at Mount SinaiUse of Circadian Reset Technology to Alter REM Sleep and Appetitive Control in Patients With Binge Eating Disorder | 2026-11 |
| NCT06532734Denver Health and Hospital AuthorityBarrett's Esophagitis in Anorexia Nervosa Binge/Purge Subtype | 2026-11 |
| NCT07740291Texas Tech UniversityTirzepatide Impact Assessment Study | 2026-11-23 |
| NCT05509257Children's Mercy Hospital Kansas CityNaltrexone Neuroimaging in Teens With Eating Disorders | 2026-12 |
| NCT07589621Florida State UniversitySafety Behavior Fading Versus Progressive Muscle Relaxation for Appearance Concerns | 2026-12 |
Add all 28 to your calendar (.ics) → With an account.
Among the 259 studies in Feeding and Eating Disorders with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Single site evidence-based implementation of a mHealth application for remote patient monitoring for pediatric patients ready to wean from tube feedings (TFs). The primary objective of this study is to evaluate the CHAMP® ("CHAMP App") software platforms' expansion into TF weaning through Children's Mercy (CM) Kansas City's interdisciplinary feeding team (IDC). The investigators will use the current standard of care rates of tube weaning success, time to weaning, and healthcare team communication to evaluate the change after the implementation of the evidence-based CHAMP App. For equipoise of access, the study team will provide access in this pre-post design for parent/legally authorized representative (LAR)- child family access and use the CHAMP App software platform as soon as possible.
Training: After consent to the study- parents/LAR will undergo training on the CHAMP App use by the study staff. The CHAMP App will be downloaded on the parent/LAR mobile device or an iPad that has been locked to contain only the CHAMP App and patient portal with mobile device management of the device by CM.
In addition to approval to begin a weaning trial by the IDC team providing primary nutrition management-beginning the weaning process may include these requirements:
CHAMP App use: Families will be provided with a weighing scale for home use; access to the CHAMP App mobile application or an iPad with the app and myChildren's Mercy App (patient portal) installed, if they prefer, during the study period. Data quality and validity will be ensured through the training of the healthcare team on data entry and out-of-range limits for each data value collected via the CHAMP web portal data entry forms. All data will be stored on the secure CM CHAMP Azure software platform with secure encryption database features.
Healthcare team CHAMP web portal use: The study team will review data entered by parents twice a week and as needed with questions and red flag concerns reported by parents/LAR. They will communicate back to parents with messages in the patient portal for documentation of messages that can be seen by other gastroenterology (GI) staff (GI clinic messages).
The IDC tube weaning algorithm (attached) will be used as a guideline for awareness of tube weaning but any changes to volume, concentration, or formula type will be reviewed and approved by an IDC provider before communicating to families.
RPM data entered by parents will be reviewed weekly by the IDC healthcare team in a team meeting organized through weekly reports of active patients enrolled in the study. This meeting will include an IDC provider, nurse, and nutritionist at minimum. There will be a summary of full study patient reports and individual patient reports available to all healthcare team members throughout the study, and these reports will be especially useful during these weekly meetings.
The IDC team works with Gastroenterology staff and fellows for 24 hours a day call. The CHAMP app will have a service pager for GI and the on-call hospital network is also available at any time for parents/LAR. On-call GI staff will be able to see feeding and weight data in Cerner under results review and CHAMP App. Videos are only available in the CHAMP web portal at champ.childrensmercy.org
Recommendation and timing for removal of feeding tubes will be up to the healthcare team alone. This event will be documented for date/time but is not a study-related intervention recommended through CHAMP App.
Additional measures to evaluate study results include:
Demographics - child and family measures: The study team will collect data on the child and family from the electronic medical record, including, but not limited to, infant medical conditions, feeding interventions, in-person healthcare visits with IDC and other specialists, language spoken, the distance of home residence from the hospital, in-home services used (Early Intervention, Physical Therapy, Occupational therapy, speech).
Nutritional measures: The study team will obtain the child's weight, length, and head circumference at birth and enrollment from the electronic medical record. The investigators will also obtain the following from the electronic medical record: weight for age and z-scores calculated by gender, weight percentiles, length/weight, mid-upper arm circumference (MUAC,) and head circumference. The investigators will use the CHAMP App to track weight at weekly intervals and obtain via parental report. There will be a weekly review, as well as on an as-needed basis, if sooner than weekly, by the IDC's research team, providers and nutrition team.
Healthcare team measures: The IDC team's periods of nutrition interventions will be evaluated for frequency of communication, including feeding interventions with families, volume changes, feeding routes, concentrations, and weight reporting frequency charted in the EMR. The time to first visit with the clinical team after referral to the IDC team, the rate of cancellation/no-show visits, and the number of patients on the wait list for enrollment in the clinical program will also be collected.
Family experience measures: Rate of first patient appointment attended, rate of attrition though never seen, cancellation and no-show appointments, time to first appointment after confirmation of visit in the calendar system, rate of follow-up frequency, graduation from the program with 100% calories by mouth with age-appropriate weight gain vs. attrition rates. Time to the healthcare recommendation of removal of feeding tube after the use of CHAMP app (by type nasogastric (NG) and gastrostomy - g-tube).
Technology measures by parents: Using the CHAMP App, the study team will track parent reported feeding volumes by mouth and tube, weights from home scales, videos of eating, and time to all feedings by mouth.
Technology adherence measures: The study team will track parent use of the app through tracking data on 1) app initiation, the first day of data transfer of CHAMP App data after enrollment; 2) implementation, the amount and type (feeding volumes, type, concentration, food amount, types, and weights) of asynchronous remote patient monitoring data received at the recommended intervals; and 3) discontinuation, the time of last data sent to the healthcare team.
Patients in the Interdisciplinary Feeding Clinic (IDC) patient population that are deemed ready to begin weaning from tube feeds.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Eligibility Criteria: Parent/LAR-Child dyad was referred for feeding difficulty and tube feeding care at Children's Mercy.
Inclusion Criteria
Children who do not meet the criteria to begin tube weaning.
Children's Mercy Kansas City's CHAMP application was developed for data transfer of pediatric cardiac population vitals from home to the healthcare team in March 2014. CHAMP provides families and the clinical team with a new model of care leveraged by a remote patient monitoring (RPM) platform. CHAMP has been used in over 1000 patients, 28 states, and across 12 pediatric hospitals in pediatric cardiology. The CHAMP application is available in 11 languages for families to use on mobile devices (Apple and Android).
Adherence Initiation
The study team will track parent use of the CHAMP App through tracking data on 1) app initiation the time of First data sent to the healthcare team.
Time frame: Time in days, one event- the first day of data transfer of CHAMP App data after enrollment
Adherence Implementation
The study team will track parent use of the CHAMP App through tracking data on implementation, the amount and type (feeding volumes, type, concentration, food amount, types (formula), and weights in kg) of asynchronous remote patient monitoring data received at the recommended intervals each week
Time frame: From enrollment to study endpoint, an average of 6 weeks
Adherence Discontinuation
The study team will track parent use of the CHAMP App through tracking data discontinuation at the time of last data sent to the healthcare team prior to completion of study activities.
Time frame: From enrollment to study endpoint, an average of 6 weeks
Success rate to tube weaning
Determine how the use of a remote patient monitoring mHealth software platform impacts the success rate (%) compared with those using only a standard outpatient interdisciplinary feeding tube using a tube weaning algorithm.
Time frame: From enrollment to study endpoint, an average of 6 weeks
Time to weaning
Determine how the use of a remote patient monitoring mHealth software platform the time (weeks) for children that were able to get 100% of calories by mouth while maintaining age-appropriate growth, compared with those using only a standard outpatient interdisciplinary feeding tube using a tube weaning algorithm.
Time frame: From enrollment to study endpoint, an average of 4 weeks
Plan to share: No
Started Nov 2023 (actual). Primary completion is estimated for Aug 2027, 45 months after the start.
Of 61 non-industry observational studies under Feeding and Eating Disorders, half reached primary completion within 42 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 95. This study's planned 45 months is close to that.
Counting every sponsor, half of 64 studies reached it within 42 months; a quarter within 18 and three quarters within 95.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Feeding and Eating Disorders →
Lori Erickson